Webinars

Back

Molostova - Oral 1.4 - Feasibility of point-of-care production of CD19 CAR T Cells in an automated closed-system bioreactor: report of first clinical experience – Thursday, Best abstracts & flash talks part I

Urbano-Ispizua - Current status of CAR-T cell development in Europe and elsewhere – Saturday, session 12

Hudecek - CAR-T cells for non-immunologists: A simple description of the technology – Saturday, session 12